Regenxbio (RGNX) FCF Margin Growth (3y) (2017 - 2025)
Regenxbio (RGNX) FCF Margin Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | -8,114.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,114.00 |
| Sep 30, 2025 | 329.00 |
| Jun 30, 2025 | -6,235.00 |
| Mar 31, 2025 | 33,846.00 |
| Dec 31, 2024 | -25,005.00 |
| Sep 30, 2024 | 18,302.00 |
| Jun 30, 2024 | -3,974.00 |
| Mar 31, 2024 | -11,173.00 |
| Dec 31, 2023 | -18,917.00 |
| Sep 30, 2023 | -18,276.00 |
| Jun 30, 2023 | -5,038.00 |
| Mar 31, 2023 | -22,013.00 |
| Dec 31, 2022 | 10,199.00 |
| Sep 30, 2022 | -4,108.00 |
| Jun 30, 2022 | 21,789.00 |
| Mar 31, 2022 | 329,085.00 |
| Dec 31, 2021 | 11,432.00 |
| Sep 30, 2021 | -6,744.00 |
| Jun 30, 2021 | -32,617.00 |
| Mar 31, 2021 | -29,546.00 |